March 5, 2019
Bexion’s cancer treatment trial enrolment reflects medical need for new treatment
Bexion’s Phase I First-In-Human Trial using BXQ-350 for the treatment of cancer has exceeded expectations in screening and enrollment at their 4 trial sites.